Effect of SOX10 gene polymorphism on early onset schizophrenia in Chinese Han population

Neuroscience Letters

Volumn 521, Issue 2, 2012, Pages 93-97

  Yuan, Aihua ^a   Yi, Zhenghui ^a   Sun, Jinhua ^a   Du, Yasong ^a   Yu, Tao ^b   Zhang, Chen ^a   Liu, Yi ^a   Zhou, Ying ^b   Liu, Dengtang ^a   Li, Huafang ^a   Xu, Yifeng ^a   Cheng, Zaohuo ^c   Li, Weidong ^b,c   Yu, Shunying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANDONG MENTAL HEALTH CENTER   (China)

Author keywords

Age at onset; Association study; Meta analysis; Schizophrenia; SOX10

Indexed keywords

TRANSCRIPTION FACTOR SOX10;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX FACTORS; SOXE TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84863108076     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.05.040     Document Type: Article

References (35)

1. Anttila S., Kampman O., Illi A., Roivas M., Mattila K.M., Lassila V., Lehtimaki T., Leinonen E. NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia. Psychiatric Genetics 2003, 13:61-64.
2. Bernstein H.G., Steiner J., Bogerts B. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Review of Neurotherapeutics 2009, 9:1059-1071.
3. De Luca V., Zai C., de Souza R., Polsinelli G., Teo C., Shinkai T., Wong A., Le Foll B., Kennedy J.L. Admixture analysis of age at onset in schizophrenia: genetic association study of 45 candidate loci. Schizophrenia Research 2012, 134:288-290.
4. Dean B., Boer S., Gibbons A., Money T., Scarr E. Recent advances in postmortem pathology and neurochemistry in schizophrenia. Current Opinion in Psychiatry 2009, 22:154-160.
5. Decoster J., van Os J., Kenis G., Henquet C., Peuskens J., De Hert M., van Winkel R. Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2011, 156B:363-369.
6. Dracheva S., Davis K.L., Chin B., Woo D.A., Schmeidler J., Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease 2006, 21:531-540.
7. Drerup C.M., Wiora H.M., Topczewski J., Morris J.A. Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation. Development 2009, 136:2623-2632.
8. Ekelund J., Hennah W., Hiekkalinna T., Parker A., Meyer J., Lonnqvist J., Peltonen L. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Molecular Psychiatry 2004, 9:1037-1041.
9. Eom S., Lee C. Functions of intronic nucleotide variants in the gene encoding pleckstrin homology like domain beta 2 (PHLDB2) on susceptibility to vascular dementia. World J Biol Psychiatry 2011, (Epub ahead of print; 2011 Nov 23).
10. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007, 39:175-191.
11. Foong J., Symms M.R., Barker G.J., Maier M., Woermann F.G., Miller D.H., Ron M.A. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 2001, 124:882-892.
12. Frangou S., Hadjulis M., Vourdas A. The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. Schizophrenia Bulletin 2008, 34:52-59.
13. Gogtay N., Lu A., Leow A.D., Klunder A.D., Lee A.D., Chavez A., Greenstein D., Giedd J.N., Toga A.W., Rapoport J.L., Thompson P.M. Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:15979-15984.
14. Goldberg X., Fatjo-Vilas M., Penades R., Miret S., Munoz M.J., Vossen H., Fananas L. Neurodevelopmental liability to schizophrenia: the complex mediating role of age at onset and premorbid adjustment. Schizophrenia Research 2011, 133:143-149.
15. Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., Malhotra A.K. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. American Journal of Human Genetics 2004, 75:862-872.
16. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., Kato T. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. Journal of Neuroscience 2005, 25:5376-5381.
17. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama Y., Yoshikawa T., Kato T. A family-based and case-control association study of SOX10 in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:477-481.
18. Kao W.T., Wang Y., Kleinman J.E., Lipska B.K., Hyde T.M., Weinberger D.R., Law A.J. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15619-15624.
19. Katsel P., Tan W., Abazyan B., Davis K.L., Ross C., Pletnikov M.V., Haroutunian V. Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophrenia Research 2011, 130:238-249.
20. Kumra S., Charles Schulz S. Editorial: research progress in early-onset schizophrenia. Schizophrenia Bulletin 2008, 34:15-17.
21. Kuspert M., Hammer A., Bosl M.R., Wegner M. Olig2 regulates Sox10 expression in oligodendrocyte precursors through an evolutionary conserved distal enhancer. Nucleic Acids Research 2011, 39:1280-1293.
22. Lai H.C., Jan L.Y. The distribution and targeting of neuronal voltage-gated ion channels. Nature Reviews Neuroscience 2006, 7:548-562.
23. Li H., Richardson W.D. The evolution of Olig genes and their roles in myelination. Neuron Glia Biology 2008, 4:129-135.
24. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., Hennah W., Peltonen L., Lonnqvist J., Huttunen M.O., Kaprio J., Trachtenberg J.T., Silva A.J., Cannon T.D. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:18280-18285.
25. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., Rowitch D.H. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109:75-86.
26. Maeno N., Takahashi N., Saito S., Ji X., Ishihara R., Aoyama N., Branko A., Miura H., Ikeda M., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Iwata N., Inada T., Ozaki N. Association of SOX10 with schizophrenia in the Japanese population. Psychiatric Genetics 2007, 17:227-231.
27. Markham J.A., Herting M.M., Luszpak A.E., Juraska J.M., Greenough W.T. Myelination of the corpus callosum in male and female rats following complex environment housing during adulthood. Brain Research 2009, 1288:9-17.
28. Papiol S., Begemann M., Rosenberger A., Friedrichs H., Ribbe K., Grube S., Schwab M.H., Jahn H., Gunkel S., Benseler F., Nave K.A., Ehrenreich H. A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2011, 156B:340-345.
29. Pozniak C.D., Langseth A.J., Dijkgraaf G.J., Choe Y., Werb Z., Pleasure S.J. Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing suppressor of fused expression. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21795-21800.
30. Pulver A.E., Brown C.H., Wolyniec P., McGrath J., Tam D., Adler L., Carpenter W.T., Childs B. Schizophrenia: age at onset, gender and familial risk. Acta Psychiatrica Scandinavica 1990, 82:344-351.
31. Rapoport J., Chavez A., Greenstein D., Addington A., Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48:10-18.
32. Sham P.C., Jones P., Russell A., Gilvarry K., Bebbington P., Lewis S., Toone B., Murray R. Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. British Journal of Psychiatry 1994, 165:466-473.
33. Taylor D.C. Differential rates of cerebral maturation between sexes and between hemispheres. Evidence from epilepsy. Lancet 1969, 2:140-142.
34. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
35. Yu Q., Sui J., Rachakonda S., He H., Gruner W., Pearlson G., Kiehl K.A., Calhoun V.D. Altered topological properties of functional network connectivity in schizophrenia during resting state: a small-world brain network study. PLoS One 2011, 6:e25423.